The drug is currently in phase 3 trials and treats moderate to severe chronic pain by applying a small piece of polymer film to the inner lining of the cheek. The film eventually dissolves.
Sign up for our FREE Pain E-Weekly for more coverage like this sent to your inbox!
Related Articles on Pain Management:
Spinal Manipulation More Effective for Neck Pain Than Medication
Arcion Receives U.S. Patent for Topical Therapy for Chronic Pain
5 Ways to Safeguard Against Opioid Abuse and Diversion From Robert Saenz, CEO of Tulsa Pain Consultants
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
